ACCURAY INCORPORATED Net Fee Amt
ACCURAY INCORPORATED (ARAY) had Net Fee Amt of $229.73 as of 2026-07-31, per its S-3 filed 2026-07-31.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-07-31
- 2026-07-31: Net Fee Amt $229.73.
| Period end | Net Fee Amt |
|---|---|
| 2026-07-31 | $229.73 S-3 · filed 2026-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |